Adequate Resources Are Key to Oncology Clinical Trial Success

Bharat Patel, MBA
Published: Tuesday, Aug 21, 2018
Bharat Patel, MBA

Bharat Patel, MBA

With all the exciting developments occurring in cancer research, community oncology practices that currently do not offer clinical trials to patients may be considering executing a research program. Before moving forward, it is important to carefully consider what is required to successfully implement a program, as well as challenges that may be encountered.

To succeed in clinical research, a community practice needs a robust patient population. The practice should be well established so that research activities do not hinder the overall success of the practice (Figure).

Another critical factor is the level of interest of the site research leader and other physicians. Within US Oncology Research, the research arm of The US Oncology Network, the level of clinical trial participation varies from site to site. The difference usually lies in the amount of the research leaders’ involvement and the practice physicians’ interest in making clinical trials available to patients.

The practice’s financial strength also is a key ingredient of success. Historically, clinical trials have been financially challenging, although there are ways to budget for an active program that do not overstress the finances of a practice. US Oncology Research, which is a network of independent clinics, has a budget model that can help guide practices. Generally, if an organization is not financially healthy without clinical research, a clinical trials program may not be feasible, and caution is advised.

Figure. Resource Basics for Successful Clinical Trial Management

Resource Basics for Successful Clinical Trial Management

Research Provides Many Benefits

Community oncology practices that are well positioned to execute a clinical research program will realize many benefits. Practices have access to innovative treatments under development, which, in turn, enables them to offer cutting-edge therapies to patients who otherwise would have to travel long distances to participate in a trial. Practices also gain access to novel therapies early in development, and physicians become familiar with the safety profiles and efficacy. That positions them for success in the use of those agents should they come to market.

As a community oncology practice weighs the value of becoming a clinical research site, several factors need careful consideration:

Physical space must be dedicated exclusively to research.

The starting point involves allocating a dedicated space to research activities. Although not all centers have a physically separate area for research-related infusion, they should have dedicated real estate in the office for clinical research functions. In addition, that area should house all things related to clinical trials, such as investigational products, lab kits, and other necessary equipment.

Physicians and staff must be knowledgeable about clinical research.

Physicians―especially the primary investigator at the site―must have a thorough understanding of the complexities involved in running a program, gained through either education or experience. Research staff also must be highly trained and competent in their respective areas to ensure the team is adequately prepared to conduct trials, with patient safety as their top priority.

Human resources are required.

Key personnel are needed to efficiently run research programs and meet regulatory obligations. A primary physician investigator is mandatory. Other necessary personnel include a clinical research manager to oversee trial execution, a clinical research coordinator (typically, a nurse who assists the physician), a data coordinator, and a pharmacist.

Various support functions require access to other key personnel, such as a finance person to help establish budgets and legal expert to execute contracts. For practices in The US Oncology Network, these functions are handled centrally, enabling them to concentrate on research rather than administrative tasks.

All the above elements are necessary, because they instill confidence in pharmaceutical companies that physicians and staff understand how to run clinical trials and that the facility has adequate resources to execute a quality trial and produce the data necessary to answer clinical questions— all while keeping patient safety at the forefront.

Clinical Trial Challenges

Opening a clinical trial can be daunting. Establishing contracts with pharmaceutical companies, developing a budget, managing the operational logistics, and meeting regulatory requirements are by far the most time-consuming activities.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 14th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®Apr 30, 20192.0
Oncology Consultations®: The Advancing Role of CAR T-Cell Therapies in Hematologic MalignanciesApr 30, 20191.5
Publication Bottom Border
Border Publication